Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph not_applicable
1
20%
Ph early_phase_1
1
20%
Ph phase_3
2
40%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(5)

Detailed Status

Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)

Trials by Status

not_yet_recruiting120%
active_not_recruiting360%
enrolling_by_invitation120%

Recent Activity

3 active trials
Showing 5 of 5
active_not_recruitingphase_3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473
enrolling_by_invitationnot_applicable

OE MRI to Predict Treatment Response After TACE in HCC Patients

NCT07617038
active_not_recruitingphase_3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486
not_yet_recruitingearly_phase_1

ImmunoMRI for Assessment of Tumor-associated Macrophages

NCT07066436
active_not_recruiting

O-RADS MRI System on Early Detection of Ovarian Cancer

NCT07009743

Clinical Trials (5)

Showing 5 of 5 trials
NCT06141473Phase 3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Active Not Recruiting
NCT07617038Not Applicable

OE MRI to Predict Treatment Response After TACE in HCC Patients

Enrolling By Invitation
NCT06141486Phase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Active Not Recruiting
NCT07066436Early Phase 1

ImmunoMRI for Assessment of Tumor-associated Macrophages

Not Yet Recruiting
NCT07009743

O-RADS MRI System on Early Detection of Ovarian Cancer

Active Not Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5